 |
 |

Molecular Identification of 7 Human Papillomavirus Types in Recurrent Respiratory Papillomatosis
Manuel Peñaloza-Plascencia, MD;
Héctor Montoya-Fuentes, MSc;
Silvia Esperanza Flores-Martínez, MSc;
Francisco Javier Fierro-Velasco, MD;
José Manuel Peñaloza-González, MD;
José Sánchez-Corona, MD, MSc
Arch Otolaryngol Head Neck Surg. 2000;126:1119-1123.
Background Recurrent respiratory papillomatosis (RRP) is the most frequent benign neoplasm in childhood; it originates as a mild dysphonia and results in asphyxia. The RRP has been associated with an infection caused by human papillomavirus (HPV), mainly types 6 and 11, the latter being associated with more severe RRP.
Objectives To analyze the frequency of the association of RRP with the HPV types in our juvenile population and to classify it according to severity.
Design Observational descriptive trial.
Materials and Methods Forty-seven samples of paraffin-embedded papillomas, from 26 female and 21 male children (age range, 2 weeks to 17 years) were analyzed. DNA was isolated and a 188base pair fragment was amplified from a consensus sequence in the E1 open reading frame of several HPVs by polymerase chain reaction. The corresponding band was recovered and reamplified. The fragment was digested with the restriction enzyme RsaI. The digestion products were compared with patterns of molecular weight markers for viral type identification. The patients' clinical records were reviewed, and RRP was classified as mild or aggressive.
Results The presence of HPV types 6, 11, 16, 31, 33, 35, or 39 was confirmed in all the cases with different combinations. The 2 test showed no significant differences in clinical aggressiveness among the viral types. A logistic regression analysis demonstrated no association between clinical aggressiveness and any viral type or viral combination.
Conclusion These results show that RRP is caused by infection with HPV types 6 and 11 in addition to many other types, with no relationship between HPV type and clinical severity.
From the Departamento de Otorrinolaringología, Hospital de Pediatría (Dr Peñaloza-Plascencia), Laboratorio de Aspectos Moleculares de Virus, Bacterias y Parásitos, División de Medicina Molecular (Mr Montoya-Fuentes, Ms Flores-Martínez, and Dr Sánchez-Corona) and División de Genética (Dr Peñaloza-González), Centro de Investigación Biomédica de Occidente, and Unidad de Anatomía Patológica, Hospital de Especialidades (Dr Fierro-Velasco), Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México. Dr Peñaloza-Plascencia is deceased.
RELATED ARTICLE
Archives of OtolaryngologyHead & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2000;126(9):1171.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The characteristics of human papillomavirus DNA in head and neck cancers and papillomas
Major et al.
J. Clin. Pathol. 2005;58:51-55.
ABSTRACT
| FULL TEXT
Clinical Course of Recurrent Respiratory Papillomatosis in Danish Children
Silverberg et al.
Arch Otolaryngol Head Neck Surg 2004;130:711-716.
ABSTRACT
| FULL TEXT
National Registry for Juvenile-Onset Recurrent Respiratory Papillomatosis
Reeves et al.
Arch Otolaryngol Head Neck Surg 2003;129:976-982.
ABSTRACT
| FULL TEXT
Can Mumps Vaccine Induce Remission in Recurrent Respiratory Papilloma?
Pashley
Arch Otolaryngol Head Neck Surg 2002;128:783-786.
ABSTRACT
| FULL TEXT
|